CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIï¾® (encorafenib) in combination with cetuximab (marketed…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Mar. 31, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
On Mar. 24, 2020, aTyr Pharma announced announced that the companyï¾’s Hong Kong subsidiary, Pangu BioPharma, together with…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
On Mar. 2, 2020,Gilead Sciences announced it had acquired Forty Seven Inc. for $95.50 per share in cash…
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…
On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 10 new recruitment grants,…
On Nov. 12, 2019, Emory University Hospital Midtown and Winship Cancer Institute of Emory University (Winship) announced they…
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…